← Bausch Health Companies Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $9.7b |
$8.7b
-9.82%
|
$8.4b
-3.94%
|
$8.6b
+2.64%
|
$8.0b
-6.67%
|
$8.4b
+5.07%
|
$8.1b
-3.68%
|
$8.8b
+7.79%
|
$9.6b
+9.91%
|
$10.3b
+6.66%
|
$10.9b
+5.72%
|
|
| Cost of Goods and Services Sold | $2.6b |
$2.5b
-2.57%
|
$2.4b
-6.19%
|
$2.4b
-0.04%
|
$2.2b
-4.30%
|
$2.4b
+6.45%
|
$2.4b
-1.25%
|
$2.6b
+8.25%
|
$2.8b
+8.71%
|
$3.0b
+8.30%
|
$3.1b
+1.49%
|
|
| Gross Profit (Calculated) | $7.1b |
$6.2b
-12.45%
|
$6.0b
-3.04%
|
$6.3b
+3.68%
|
$5.8b
-7.57%
|
$6.0b
+4.53%
|
$5.8b
-4.64%
|
$6.2b
+7.60%
|
$6.8b
+10.41%
|
$7.3b
+5.99%
|
— | |
| Selling, General and Administrative Expense | $2.8b | $2.6b | $2.5b | $2.6b | $2.4b | $2.6b | $2.6b | $2.9b | $3.3b | $3.4b | $3.4b | |
| Operating Income (Loss) | ($566.0m) |
$102.0m
+118.02%
|
($2.4b)
-2437.25%
|
($203.0m)
+91.48%
|
$676.0m
+433.00%
|
$450.0m
-33.43%
|
$454.0m
+0.89%
|
$963.0m
+112.11%
|
$1.5b
+60.54%
|
$1.8b
+17.27%
|
$2.7b
+50.69%
|
|
| Interest Expense, Debt | — | — | — | $1.6b | $1.5b | $1.4b | $1.5b | $1.3b | $1.4b | $1.6b | $1.6b | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($41.0m) | $107.0m | $23.0m | $8.0m | ($30.0m) | $7.0m | ($8.0m) | ($52.0m) | ($47.0m) | ($52.0m) | — | |
| Gain (Loss) on Investments | $0 | — | — | — | — | — | — | — | — | — | — | |
| Gain (Loss) Related to Litigation Settlement | ($59.0m) | ($226.0m) | $27.0m | ($1.4b) | ($422.0m) | ($356.0m) | ($9.0m) | $53.0m | ($220.0m) | ($61.0m) | — | |
| Other Nonoperating Income (Expense) | ($73.0m) | $353.0m | $21.0m | ($1.4b) | ($454.0m) | ($373.0m) | ($35.0m) | ($28.0m) | ($247.0m) | ($142.0m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($1.8b) | ($2.0b) | ($1.5b) | ($2.4b) | ($410.0m) | ($323.0m) | $64.0m | ($382.0m) | ($596.0m) | ($743.0m) | ($732.0m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | $1.8b | $934.0m | ($1.0b) | ($129.0m) | ($390.0m) | $167.0m | $367.0m | ($732.0m) | |
| Current Income Tax Expense (Benefit) | $241.0m | $166.0m | $327.0m | $128.0m | $224.0m | ($51.0m) | $271.0m | $215.0m | $170.0m | $115.0m | $361.0m | |
| Income Tax Expense (Benefit) | ($27.0m) | ($4.1b) | ($10.0m) | ($54.0m) | ($375.0m) | ($87.0m) | $83.0m | $221.0m | $239.0m | $247.0m | $361.0m | |
| Net Income (Loss) Attributable to Parent | ($2.4b) |
$2.4b
+199.79%
|
($4.1b)
-272.55%
|
($1.8b)
+56.89%
|
($560.0m)
+68.68%
|
($948.0m)
-69.29%
|
($225.0m)
+76.27%
|
($592.0m)
-163.11%
|
($46.0m)
+92.23%
|
$157.0m
+441.30%
|
($1.1b)
-799.36%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.0m | $0 | $4.0m | $5.0m | $1.0m | $11.0m | $13.0m | ($19.0m) | ($26.0m) | ($37.0m) | ($1.1b) | |
| Earnings Per Share, Basic | ($6.94) | $6.86 | ($11.81) | ($5.08) | ($1.58) | ($2.64) | ($0.62) | ($1.62) | ($0.13) | $0.42 | ($2.94) | |
| Earnings Per Share, Diluted | ($6.94) | $6.83 | ($11.81) | ($5.08) | ($1.58) | ($2.64) | ($0.62) | ($1.62) | ($0.13) | $0.42 | ($2.94) | |
| Weighted Average Number of Shares Outstanding, Basic | 347.3m | 350.2m | 351.3m | 352.1m | — | 358.9m | 362.0m | 364.9m | 368.0m | 370.9m | 372.7m | |
| Weighted Average Number of Shares Outstanding, Diluted | 347.3m | 351.8m | 351.3m | 352.1m | — | 358.9m | 362.0m | 364.9m | 368.0m | 375.0m | 375.2m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | $2.0m | — | — | $8.0m | $0 | $11.0m | $29.0m | $24.0m | $4.0m | $9.0m | — | |
| Costs and Expenses | $10.2b | $8.6b | $10.8b | $8.8b | $7.4b | $8.0b | $7.7b | $7.8b | $8.1b | $8.5b | — | |
| Goodwill, Impairment Loss | $1.1b | $312.0m | $2.3b | $0 | — | $469.0m | $824.0m | $493.0m | — | $145.0m | $1.6b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.